Legal Opinion

Abbvie Endocrine Inc. v. Takeda Pharmaceutical Company Limited

Court of Chancery of Delaware

Decided September 7, 2021No. 2020-0953-SGPublished

1Opinion of the Court

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE ABBVIE ENDOCRINE INC., ) ) Plaintiff, ) ) v. ) C.A. No. 2020-0953-SG ) TAKEDA PHARMACEUTICAL ) COMPANY LIMITED, ) ) Defendant. ) MEMORANDUM OPINION Date Submitted: August 3, 2021 Date Decided: September 7, 2021 A. Thompson Bayliss and Joseph A. Sparco, of ABRAMS & BAYLISS LLP, Wilmington, Delaware; OF COUNSEL: Paul J. Loh, Jason H. Wilson, Peter Shimamoto, Ashley L. Kirk, Lika C. Miyake, Amelia L.B. Sargent, and Kenneth M. Trujillo-Jamison, of WILLENKEN LLP, Los Angeles, California, Attorneys for Plaintiff AbbVie Endocrine Inc. Kevin R.…

2Cases cited3 opinions

  1. Lemon v. KurtzmanSupreme Court of the United States · 1973
  2. Equitable Trust Co. v. GallagherSupreme Court of Delaware · 1954
  3. Northern Delaware Industrial Development Corp. v. E. W. Bliss Co.Court of Chancery of Delaware · 1968

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API